Tamiflu has been used in countries ... authors of the review, Cochrane Neuraminidase Inhibitors Review Team, said: "Drug approval and use cannot be based on biased or missing information any ...

Roche is hoping the new drug can breathe new life into its flu franchise, represented by older neuraminidase inhibitor Tamiflu (oseltamivir). That was a $3 billion brand at its peak, but has ...

It combines a neuraminidase inhibitor with an antibody fragment to ... % for placebo and significantly lowered viral load, with no drug‑related adverse events reported. After reacquiring full ...

we have been issued approximately 44 U.S. patents that expire between 2027 and 2039 and that relate to our kallikrein inhibitor compounds, neuraminidase inhibitor compounds, broad-spectrum ...

The 2009 influenza pandemic A(H1N1)pdm09 of swine origin and the continued circulation of highly pathogenic avian H5N1 strain in humans are stark reminders of the unpredictable nature of the ...

Selective inhibitors of COX-2-selective NSAIDs are effective antiinflammatory and analgesic drugs with improved upper-GI safety compared to traditional NSAIDs. Data on the cost-effectiveness of ...